DK170099B1 - t-Butyl-ergolin-derivativer, fremgangsmåde til fremstilling deraf, samt farmaceutiske præparater indeholdende disse - Google Patents

t-Butyl-ergolin-derivativer, fremgangsmåde til fremstilling deraf, samt farmaceutiske præparater indeholdende disse Download PDF

Info

Publication number
DK170099B1
DK170099B1 DK322587A DK322587A DK170099B1 DK 170099 B1 DK170099 B1 DK 170099B1 DK 322587 A DK322587 A DK 322587A DK 322587 A DK322587 A DK 322587A DK 170099 B1 DK170099 B1 DK 170099B1
Authority
DK
Denmark
Prior art keywords
ergoline
butyl
formula
methyl
hydrogen atom
Prior art date
Application number
DK322587A
Other languages
Danish (da)
English (en)
Other versions
DK322587D0 (da
DK322587A (da
Inventor
Aldemio Temperilli
Enzo Brambilla
Mauro Gobbini
Maria Antonietta Cervini
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of DK322587D0 publication Critical patent/DK322587D0/da
Publication of DK322587A publication Critical patent/DK322587A/da
Application granted granted Critical
Publication of DK170099B1 publication Critical patent/DK170099B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Graft Or Block Polymers (AREA)
  • Developing Agents For Electrophotography (AREA)
DK322587A 1986-06-25 1987-06-24 t-Butyl-ergolin-derivativer, fremgangsmåde til fremstilling deraf, samt farmaceutiske præparater indeholdende disse DK170099B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868615471A GB8615471D0 (en) 1986-06-25 1986-06-25 T-butyl ergoline derivatives
GB8615471 1986-06-25

Publications (3)

Publication Number Publication Date
DK322587D0 DK322587D0 (da) 1987-06-24
DK322587A DK322587A (da) 1987-12-26
DK170099B1 true DK170099B1 (da) 1995-05-22

Family

ID=10600059

Family Applications (1)

Application Number Title Priority Date Filing Date
DK322587A DK170099B1 (da) 1986-06-25 1987-06-24 t-Butyl-ergolin-derivativer, fremgangsmåde til fremstilling deraf, samt farmaceutiske præparater indeholdende disse

Country Status (20)

Country Link
US (2) US4843073A (de)
EP (1) EP0251652B1 (de)
JP (1) JPH0745498B2 (de)
KR (1) KR950008970B1 (de)
AT (1) ATE76407T1 (de)
AU (1) AU597672B2 (de)
CA (1) CA1339533C (de)
DE (1) DE3779190D1 (de)
DK (1) DK170099B1 (de)
ES (1) ES2042567T3 (de)
FI (1) FI85702C (de)
GB (1) GB8615471D0 (de)
GR (1) GR3005115T3 (de)
HU (1) HU196201B (de)
IE (1) IE61319B1 (de)
IL (1) IL82946A (de)
NZ (1) NZ220543A (de)
PT (1) PT85152B (de)
SU (1) SU1547708A3 (de)
ZA (1) ZA874569B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61245164A (ja) * 1985-04-23 1986-10-31 Seiko Instr & Electronics Ltd パタ−ン修正装置
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
WO2014195849A2 (en) * 2013-06-03 2014-12-11 Mahesh Kandula Compositions and methods for the treatment of cerebrovascular diseases

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228941A (en) * 1966-01-11 Methyl and i,g-dimethyl-ergoline i derivatives
US3228942A (en) * 1966-01-11 Methyl and i,g-dimeti-iyl ergoline i compounds
US3228945A (en) * 1966-01-11 Methyl and i,g-dimethyl-b-(a-hydroxy- alkyl)-ergoline i derivatives
DE203721C (de) * 1908-05-05
US3232942A (en) * 1964-06-02 1966-02-01 Sandoz Ltd 1-substituted (+)-lysergol
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
USRE30218E (en) * 1974-12-06 1980-02-19 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
GB2056437A (en) * 1979-08-07 1981-03-18 Erba Farmitalia Secoergoline derivatives
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
DE3403067A1 (de) * 1984-01-30 1985-08-14 Eckart Prof. Dr. 6500 Mainz Eich Ergolin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
IT1213206B (it) * 1984-08-07 1989-12-14 Inverni Della Beffa Spa Procedimento per la preparazione di derivati del lisergolo.
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
AU7914587A (en) * 1987-08-24 1989-03-31 Molecular Control Corporation Liquid crystal micelles, display, having concentric spheres

Also Published As

Publication number Publication date
IE61319B1 (en) 1994-11-02
EP0251652B1 (de) 1992-05-20
US5079364A (en) 1992-01-07
FI85702C (fi) 1992-05-25
NZ220543A (en) 1989-06-28
FI872752A (fi) 1987-12-26
SU1547708A3 (ru) 1990-02-28
ATE76407T1 (de) 1992-06-15
GB8615471D0 (en) 1986-07-30
KR950008970B1 (ko) 1995-08-10
ES2042567T3 (es) 1993-12-16
EP0251652A2 (de) 1988-01-07
GR3005115T3 (de) 1993-05-24
DE3779190D1 (de) 1992-06-25
ZA874569B (en) 1988-02-24
IL82946A0 (en) 1987-12-20
DK322587D0 (da) 1987-06-24
IE871652L (en) 1987-12-25
CA1339533C (en) 1997-11-11
PT85152B (pt) 1990-03-30
HU196201B (en) 1988-10-28
AU597672B2 (en) 1990-06-07
FI85702B (fi) 1992-02-14
JPH0745498B2 (ja) 1995-05-17
HUT44543A (en) 1988-03-28
IL82946A (en) 1991-04-15
DK322587A (da) 1987-12-26
FI872752A0 (fi) 1987-06-22
AU7463287A (en) 1988-01-07
PT85152A (en) 1987-07-01
JPS6322577A (ja) 1988-01-30
KR880000429A (ko) 1988-03-25
EP0251652A3 (en) 1989-04-05
US4843073A (en) 1989-06-27

Similar Documents

Publication Publication Date Title
EP0212535A1 (de) N6-Disubstituierte Purinderivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
JPH05501265A (ja) 新規なキサンチン誘導体
US4277476A (en) Derivatives of fluorenes and fluoranthenes and process for their preparation
EP0030351B1 (de) Ergolin-Derivate, ihre Herstellung und sie enthaltende therapeutische Zusammensetzung
DK170099B1 (da) t-Butyl-ergolin-derivativer, fremgangsmåde til fremstilling deraf, samt farmaceutiske præparater indeholdende disse
US4634708A (en) Indolophenanthridines useful as dopaminergic and analgesic agents
JP3466527B2 (ja) 新規なアコニチン系化合物および鎮痛・抗炎症剤
US4555570A (en) Substituted 4-alkyl-2-(1H) quinazolinone-1-alkanoic acid derivatives
IE49920B1 (en) Vincaminic acid derivatives and process for their preparation
US3563990A (en) 1-substituted-4-aryl-2(1h)-quinazolinones
US3962262A (en) 1,8-naphthyridine compounds
US3917833A (en) Amino-substituted benzocycloheptenones for inducing sleep
US3324133A (en) 2-nitrogen 6-methyl and 1, 6-dimethylergoline derivatives
FR2531709A1 (fr) Diazabicyclooctanes, procede pour leur preparation et compositions pharmaceutiques les renfermant
US3280145A (en) New indole derivatives and their acid addition salts
EP0015786B1 (de) Imidazo und Pyrimido-Pyrido-Indole, ihre Herstellung und sie enthaltende Arzneimittel
EP0168197A2 (de) Eburnamoninoxim-Derivate und ihre Herstellung und die sie enthaltenden Arzneimittel
US3657270A (en) 1-phenyl-1h-indazole-4-acetic acids
US3576004A (en) Novel ring-e substituted 4-cyano-3-secoyohimbanes
AU638874B2 (en) Ergoline derivatives useful as dopamine antagonistic agents
US3373166A (en) Novel 17-[(methylthio)methoxy] yohimbanes
EP0043811A1 (de) Indolonaphthyridine und ihre Verwendung als Arzneimittel
EP0012347A1 (de) 7,8,9,10-Tetrahydrothieno(3,2-e)pyrido(4,3-b)indole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
HU182754B (en) Process for preparing tetrahydro-2h-benzo/c/pyrrole derivatives
EP0014792B1 (de) Tetrahydro-2H-benz(c)pyrrole, ihre Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und die Verwendungen zur Anwendung als pharmazeutika

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed